Cerebral Oxymetry at Elective Coronary and Valve Surgery. (Co-HLM)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT01940874
First received: September 9, 2013
Last updated: October 8, 2013
Last verified: October 2013

September 9, 2013
October 8, 2013
February 2011
March 2013   (final data collection date for primary outcome measure)
Cerebral oxymetry values [ Time Frame: March 2013 ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01940874 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Cerebral Oxymetry at Elective Coronary and Valve Surgery.
Cerebral Oxymetry at Elective Coronary and Valve Surgery: An Observational Study Using Norepinephrine to Maintain Arterial Blood Pressure on Cardio Pulmonary Bypass.

Use of vasopressor to maintain Mean Arterial Pressure on Cardio Pulmonary Bypass can lead to decreased cerebral flow and oxygenation in individual patients and this can be detected by means of cerebral oxymetry.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

We want to include 50 patients, both women and men, undergo elective coronary bypass surgery or valve surgeon in CPB with moderate hypothermia.

  • Coronary Artery Disease.
  • Aortic Valve Stenosis.
  • Aortic Valve Regurgitation.
Not Provided
Cerebral oximetry
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
54
March 2013
March 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patient age under 80.
  • Patients should undergo elective coronary artery bypass grafting surgery (ACB) or heart valve surgery (AVR or MVR).
  • The patient must be admitted at least 18 years of years.

Exclusion Criteria:

  • Damage to the frontal lobes corresponding to the area where SCO2 monitored.
  • Patients in pharmacological studies.
  • Patients with known intracranial vascular anomalies or cerebral aneurysms.
  • Patients with known neurological disease.
  • Patients with known undergone cerebral insult, TIA or carotid stenosis.
Both
18 Years to 80 Years
No
Contact information is only displayed when the study is recruiting subjects
Norway
 
NCT01940874
2010/823
No
Oslo University Hospital
Oslo University Hospital
Not Provided
Principal Investigator: Ove A. Hagen, MD Oslo Ùniversity Hospital
Oslo University Hospital
October 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP